Mylan to host Investor Day

American Pharmacy News Reports | Feb 22, 2017
CEO Heather Bresch and other senior leaders will present on the company’s financial guidance.
CEO Heather Bresch and other senior leaders will present on the company’s financial guidance. | Contributed image
Global pharmaceutical maker Mylan will host Investor Day on March 1 in New York City.
CEO Heather Bresch and other senior leaders will present on the company’s financial guidance for the year as well as the company’s growth strategies.
The presentation will be broadcast at 1 p.m. EST. Those wishing to watch the broadcast may log on at http://investor.mylan.com at least 15 minutes before the start of the presentation is to begin.

More News

B. Douglas Hoey CEO

State Issues Tennessee enacts law banning pharmacy benefit managers from owning pharmacies May 22, 2026

Anne McDonald Pritchett, PhD, founder of Pritchett Policy Associates

Industry Pritchett Policy Associates founder Pritchett on biosimilar access: 'PBMs are the problem not patents' May 22, 2026

Ryan Long, Director of Congressional Relations & Senior Research Fellow at Paragon Health Institute

Federal Issues Paragon Health Institute senior fellow calls for 340B reform: Primary recipients of 340B are ‘wealthier larger hospital systems’ May 22, 2026

West Cuthbert, Senior Fellow, American Resolve Action

Federal Issues American Resolve Action Senior Fellow on 340B reform: Oversight 'could prevent billions of dollars in annual waste, fraud, and abuse' May 22, 2026

B. Douglas Hoey CEO

State Issues NCPA supports pharmacy bills being marked up in House committees May 21, 2026

B. Douglas Hoey CEO

State Issues NCPA responds to HHS OIG report on vertical integration in Medicare Part D May 21, 2026

Trending

Diana Harshbarger, U.S. Representative for Tennessee's 1st District

Rep. Harshbarger calls for PBM transparency, oversight: 'It’s time to shine a light on their shady practices'

Ted Okon, MBA, Executive Director, Community Oncology Alliance

Community Oncology Alliance Executive Director Okon on 340B: ‘Expanding participation in a flawed program isn’t reform’

Anne McDonald Pritchett, PhD, founder of Pritchett Policy Associates

Pritchett Policy Associates founder Pritchett on biosimilar access: 'PBMs are the problem not patents'

Melissa Magstadt, Secretary of Health

South Dakota announces first awards for Rural Health Transformation grant program management

West Cuthbert, Senior Fellow, American Resolve Action

American Resolve Action Senior Fellow on 340B reform: Oversight 'could prevent billions of dollars in annual waste, fraud, and abuse'